Decode Health announces new partnership with Briya
The partnership will enable the respective customers of the companies and other researchers to access high-resolution data and related analytics that will advance the development of clinical support tools, better diagnostic testing, and new healthcare treatments.
Decode Health, a Nashville-based precision medicine analytics company, and Briya, an end-to-end decentralized data exchange platform also based in Nashville with offices in Tel Aviv, have announced a partnership to accelerate innovation projects that seek to improve patient outcomes and advance precision medicine.
According to this news release, the partnership will leverage Briya’s platform and Decode’s data framework and analytics that integrates multiple data sources ranging from clinical data to genomics to bring disease outcomes into focus.
Earlier this year, we spotlighted Decode Health in this teknovation.biz article the nearly decade of progress that the team behind Decode Health had been making as it built a framework leveraging a variety of advanced machine learning approaches to power an ecosystem of industry-leading diagnostic and pharmaceutical companies. The company’s flexible, scalable approach layers clinical data with social determinants of health (SDoH) and non-clinical data to fuel innovation and advance precision medicine. Decode’s data assets, products, and services improve patient outcomes, lower costs, and promote health equity.
The partnership between Decode Health and Briya will enable their respective customers and other researchers to access high-resolution data and related analytics that will advance the development of clinical support tools, better diagnostic testing, and new treatments.
“Decode is excited to partner with Briya to further the exchange of data and the use of machine learning to improve health,” said Chase Spurlock, Chief Executive Officer of Decode Health. “Our strategic relationship with Briya complements our capabilities and ongoing partnerships with diagnostic and pharmaceutical companies looking to accelerate speed to value and commercialize innovations faster.”